Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10493071 Use of pyrroloquinoline compounds to kill clinically latent microorganisms

Patent 10493071 was granted and assigned to Helperby Therapeutics on December, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Helperby Therapeutics

Current Assignee

Helperby Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10493071

Patent Inventor Names

David Edward Clark0

Anthony Coates0

Petra Helga Beck0

Thomas David Pallin0

Yanmin Hu0

Derek John Londesbrough0

Gary Patrick Reid0

Gerlinda Stoddart0

...

Date of Patent

December 3, 2019

Patent Application Number

15608032

Date Filed

May 30, 2017

Patent Citations Received

‌

US Patent 11530218 Spiro compounds as inhibitors of KRAS

‌

US Patent 11999752 Vinyl imidazole compounds as inhibitors of KRAS

‌

US Patent 11939328 Quinoline compounds as inhibitors of KRAS

‌

US Patent 11767320 Bicyclic dione compounds as inhibitors of KRAS

Patent Primary Examiner

‌

Bethany P Barham

Patent abstract

There is provided the use of compounds of formula I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10493071 Use of pyrroloquinoline compounds to kill clinically latent microorganisms

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API